These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37090247)

  • 21. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.
    Dannappel M; Vlantis K; Kumari S; Polykratis A; Kim C; Wachsmuth L; Eftychi C; Lin J; Corona T; Hermance N; Zelic M; Kirsch P; Basic M; Bleich A; Kelliher M; Pasparakis M
    Nature; 2014 Sep; 513(7516):90-4. PubMed ID: 25132550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease.
    Malireddi RKS; Gurung P; Kesavardhana S; Samir P; Burton A; Mummareddy H; Vogel P; Pelletier S; Burgula S; Kanneganti TD
    J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31869420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
    Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
    J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
    Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
    Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
    Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
    Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group.
    Hamilton GL; Chen H; Deshmukh G; Eigenbrot C; Fong R; Johnson A; Kohli PB; Lupardus PJ; Liederer BM; Ramaswamy S; Wang H; Wang J; Xu Z; Zhu Y; Vucic D; Patel S
    Bioorg Med Chem Lett; 2019 Jun; 29(12):1497-1501. PubMed ID: 31000154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X
    Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
    Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
    Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting RIPK1 kinase for modulating inflammation in human diseases.
    Li W; Yuan J
    Front Immunol; 2023; 14():1159743. PubMed ID: 36969188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.
    Jacobsen AV; Pierotti CL; Lowes KN; Au AE; Zhang Y; Etemadi N; Fitzgibbon C; Kersten WJA; Samson AL; van Delft MF; Huang DCS; Sabroux HJ; Lessene G; Silke J; Murphy JM
    Cell Death Dis; 2022 Apr; 13(4):291. PubMed ID: 35365636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
    Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
    Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.
    Li Z; Hao Y; Yang C; Yang Q; Wu S; Ma H; Tian S; Lu H; Wang J; Yang T; He S; Zhang X
    Eur J Med Chem; 2022 Jan; 228():114036. PubMed ID: 34906762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury.
    Delehouzé C; Leverrier-Penna S; Le Cann F; Comte A; Jacquard-Fevai M; Delalande O; Desban N; Baratte B; Gallais I; Faurez F; Bonnet MC; Hauteville M; Goekjian PG; Thuillier R; Favreau F; Vandenabeele P; Hauet T; Dimanche-Boitrel MT; Bach S
    Sci Rep; 2017 Oct; 7(1):12931. PubMed ID: 29018243
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Zhang H; Xu L; Qin X; Chen X; Cong H; Hu L; Chen L; Miao Z; Zhang W; Cai Z; Zhuang C
    J Med Chem; 2019 Jul; 62(14):6665-6681. PubMed ID: 31095385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation.
    Kumari S; Van TM; Preukschat D; Schuenke H; Basic M; Bleich A; Klein U; Pasparakis M
    Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33858959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potent inhibitory role of suppressing TBK1 in RIPK1 associated cerebral ischemia-reperfusion injury.
    Yang Y; Li H; Yang C; Kong X; Wu X; Gong M; Li Y
    Brain Res; 2022 Apr; 1781():147813. PubMed ID: 35120903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events.
    Delanghe T; Dondelinger Y; Bertrand MJM
    Trends Cell Biol; 2020 Mar; 30(3):189-200. PubMed ID: 31959328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis.
    In EJ; Lee Y; Koppula S; Kim TY; Han JH; Lee KH; Kang TB
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation.
    Tu H; Xiong W; Zhang J; Zhao X; Lin X
    Nat Commun; 2022 Nov; 13(1):6603. PubMed ID: 36329033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.